lobbying_activities: 2682886

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2682886	2ea949be-1830-4af0-9e84-0518d42f8dad	Q3	TIBER CREEK GROUP	20744	TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)	2021	third_quarter	CPT	H.R. 2873 - Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; S.1435 - Affordable Prescriptions for Patients Act of 2021; H.R. 2891 - Preserve Access to Affordable Generics and Biosimilars Act.	Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2021-10-16T14:41:25.147000-04:00